Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases AF Zuluaga, BE Salazar, CA Rodriguez, AX Zapata, M Agudelo, O Vesga BMC infectious diseases 6, 1-10, 2006 | 240 | 2006 |
Etiologic diagnosis of chronic osteomyelitis: a prospective study AF Zuluaga, W Galvis, JG Saldarriaga, M Agudelo, BE Salazar, O Vesga Archives of internal medicine 166 (1), 95-100, 2006 | 191 | 2006 |
Generic Vancomycin Products Fail In Vivo despite Being Pharmaceutical Equivalents of the Innovator O Vesga, M Agudelo, BE Salazar, CA Rodriguez, AF Zuluaga Antimicrobial agents and chemotherapy 54 (8), 3271-3279, 2010 | 151 | 2010 |
Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: an observational study AF Zuluaga, W Galvis, F Jaimes, O Vesga BMC infectious diseases 2, 1-7, 2002 | 144 | 2002 |
Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics AF Zuluaga, M Agudelo, CA Rodriguez, O Vesga BMC Clinical Pharmacology 9, 1-11, 2009 | 110 | 2009 |
Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model AF Zuluaga, M Agudelo, JJ Cardeño, CA Rodriguez, O Vesga PloS one 5 (5), e10744, 2010 | 76 | 2010 |
In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin CA Rodriguez, M Agudelo, AF Zuluaga, O Vesga BMC infectious diseases 10, 1-12, 2010 | 68 | 2010 |
Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model CA Rodriguez, M Agudelo, AF Zuluaga, O Vesga Antimicrobial agents and chemotherapy 56 (1), 243-247, 2012 | 58 | 2012 |
Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia CA Rodriguez, M Agudelo, JC Cataño, AF Zuluaga, O Vesga Journal of Infection 59 (4), 277-280, 2009 | 47 | 2009 |
Optimization of culture conditions to obtain maximal growth of penicillin-resistant Streptococcus pneumoniae AV Restrepo, BE Salazar, M Agudelo, CA Rodriguez, AF Zuluaga, ... BMC microbiology 5, 1-8, 2005 | 41 | 2005 |
Toxicity induced by multiple high doses of vitamin B12 during pernicious anemia treatment: a case report J Morales-Gutierrez, S Díaz-Cortés, MA Montoya-Giraldo, AF Zuluaga Clinical Toxicology 58 (2), 129-131, 2020 | 32 | 2020 |
Burden of paraquat poisoning in the department of Antioquia, Colombia JA Buendía, GJR Chavarriaga, AF Zuluaga BMC pharmacology and toxicology 20, 1-7, 2019 | 32 | 2019 |
Impact on bacterial resistance of therapeutically nonequivalent generics: the case of piperacillin-tazobactam CA Rodriguez, M Agudelo, YA Aguilar, AF Zuluaga, O Vesga PLoS One 11 (5), e0155806, 2016 | 27* | 2016 |
In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products CA Rodriguez, M Agudelo, AF Zuluaga, O Vesga International journal of antimicrobial agents 49 (2), 189-197, 2017 | 26 | 2017 |
¿Es necesaria la profilaxis antibiótica en la ofidiotoxicosis? J Cuesta, L Peña, AF Zuluaga Infectio 12 (1), 54-63, 2008 | 26 | 2008 |
R.(2011) M Uribe, AF Zuluaga, L Valencia, E Murgueitio, A Zapata, LS Solarte Costos para la toma de decisiones, 0 | 26 | |
Protocolo manejo del paciente intoxicado LM Peña, A Zuluaga Universidad de Antioquia, 2017 | 23* | 2017 |
Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacin CA Rodriguez, M Agudelo, AF Zuluaga, O Vesga Antimicrobial agents and chemotherapy 59 (1), 53-58, 2015 | 23 | 2015 |
Caracterización de los casos de accidente ofídico atendidos por el Centro de Información y Estudio de Medicamentos y Tóxicos (CIEMTO) de Medellín, Colombia durante 2016 AF García, RG Bedoya, MA Montoya, CA Rodríguez, AF Zuluaga Revista de la Universidad Industrial de Santander. Salud 49 (3), 450-457, 2017 | 22 | 2017 |
Perspectives for the structure-based design of acetylcholinesterase reactivators R Ochoa, CA Rodriguez, AF Zuluaga Journal of Molecular Graphics and Modelling 68, 176-183, 2016 | 20 | 2016 |